S&P 500   3,030.07 (-2.77%)
DOW   26,196.27 (-2.82%)
QQQ   209.26 (-3.34%)
AAPL   278.98 (-4.67%)
MSFT   161.57 (-5.05%)
GOOGL   1,338.76 (-3.72%)
AMZN   1,909.20 (-3.56%)
CGC   18.79 (-5.20%)
NVDA   259.99 (-2.86%)
BABA   206.81 (-0.92%)
MU   51.80 (-1.09%)
TSLA   689.66 (-11.45%)
AMD   44.99 (-5.26%)
T   36.27 (-2.24%)
ACB   1.45 (-3.97%)
F   7.10 (-1.66%)
NFLX   378.67 (-0.15%)
PRI   117.49 (-2.21%)
BAC   29.59 (-3.40%)
DIS   119.87 (-2.83%)
GILD   73.14 (-2.09%)
S&P 500   3,030.07 (-2.77%)
DOW   26,196.27 (-2.82%)
QQQ   209.26 (-3.34%)
AAPL   278.98 (-4.67%)
MSFT   161.57 (-5.05%)
GOOGL   1,338.76 (-3.72%)
AMZN   1,909.20 (-3.56%)
CGC   18.79 (-5.20%)
NVDA   259.99 (-2.86%)
BABA   206.81 (-0.92%)
MU   51.80 (-1.09%)
TSLA   689.66 (-11.45%)
AMD   44.99 (-5.26%)
T   36.27 (-2.24%)
ACB   1.45 (-3.97%)
F   7.10 (-1.66%)
NFLX   378.67 (-0.15%)
PRI   117.49 (-2.21%)
BAC   29.59 (-3.40%)
DIS   119.87 (-2.83%)
GILD   73.14 (-2.09%)
S&P 500   3,030.07 (-2.77%)
DOW   26,196.27 (-2.82%)
QQQ   209.26 (-3.34%)
AAPL   278.98 (-4.67%)
MSFT   161.57 (-5.05%)
GOOGL   1,338.76 (-3.72%)
AMZN   1,909.20 (-3.56%)
CGC   18.79 (-5.20%)
NVDA   259.99 (-2.86%)
BABA   206.81 (-0.92%)
MU   51.80 (-1.09%)
TSLA   689.66 (-11.45%)
AMD   44.99 (-5.26%)
T   36.27 (-2.24%)
ACB   1.45 (-3.97%)
F   7.10 (-1.66%)
NFLX   378.67 (-0.15%)
PRI   117.49 (-2.21%)
BAC   29.59 (-3.40%)
DIS   119.87 (-2.83%)
GILD   73.14 (-2.09%)
S&P 500   3,030.07 (-2.77%)
DOW   26,196.27 (-2.82%)
QQQ   209.26 (-3.34%)
AAPL   278.98 (-4.67%)
MSFT   161.57 (-5.05%)
GOOGL   1,338.76 (-3.72%)
AMZN   1,909.20 (-3.56%)
CGC   18.79 (-5.20%)
NVDA   259.99 (-2.86%)
BABA   206.81 (-0.92%)
MU   51.80 (-1.09%)
TSLA   689.66 (-11.45%)
AMD   44.99 (-5.26%)
T   36.27 (-2.24%)
ACB   1.45 (-3.97%)
F   7.10 (-1.66%)
NFLX   378.67 (-0.15%)
PRI   117.49 (-2.21%)
BAC   29.59 (-3.40%)
DIS   119.87 (-2.83%)
GILD   73.14 (-2.09%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Voyager TherapeuticsAptose BiosciencesAutolus TherapeuticsTranslate BioPrecision BioSciences
SymbolNASDAQ:VYGRNASDAQ:APTONASDAQ:AUTLNASDAQ:TBIONASDAQ:DTIL
Price Information
Current Price$10.89$7.74$8.78$7.44$7.79
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$28.00$10.25$25.00$20.75$22.80
% Upside from Price Target157.12% upside32.43% upside184.74% upside178.90% upside192.68% upside
Trade Information
Market Cap$396.28 million$539.95 million$366.13 million$436.96 million$395.65 million
Beta2.511.940.880.85N/A
Average Volume267,6071,052,426168,064145,326501,013
Sales & Book Value
Annual Revenue$7.62 millionN/A$1.41 million$1.42 million$10.88 million
Price / Sales52.98N/A250.01314.4736.37
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.43 per share$0.37 per shareN/A$2.78 per shareN/A
Price / Book7.62N/A2.68
Profitability
Net Income$-88,290,000.00$-28,870,000.00$-12,860,000.00$-97,390,000.00$-46,040,000.00
EPS($2.75)($0.86)($1.42)($3.64)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-72.64%N/A-3,576.93%-1,732.61%-423.14%
Return on Equity (ROE)-57.32%-109.51%-39.54%-59.18%-78.51%
Return on Assets (ROA)-15.83%-92.61%-33.58%-25.17%-35.67%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.04%0.09%0.62%N/A
Current Ratio4.09%7.83%12.65%8.62%9.25%
Quick Ratio4.09%7.83%12.65%8.62%9.25%
Ownership Information
Institutional Ownership Percentage85.69%40.33%24.55%86.28%45.32%
Insider Ownership Percentage33.60%7.34%N/A15.40%N/A
Miscellaneous
Employees123N/AN/A81127
Shares Outstanding37.07 million76.11 million40.15 million60.02 million50.79 million
Next Earnings Date3/3/2020 (Confirmed)3/10/2020 (Confirmed)3/3/2020 (Confirmed)3/19/2020 (Estimated)3/10/2020 (Confirmed)
OptionableOptionableOptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel